Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients
Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study was to investigate the prevalen...
Saved in:
Published in | PloS one Vol. 16; no. 11; p. e0260112 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
16.11.2021
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
ISSN | 1932-6203 1932-6203 |
DOI | 10.1371/journal.pone.0260112 |
Cover
Abstract | Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study was to investigate the prevalence and determinants of these vaccinations in this population.
Multimorbid patients aged ≥70 years with polypharmacy were enrolled in 4 European centers in Switzerland, Belgium, the Netherlands, and Ireland. Data on vaccinations, demographics, health care contacts, and comorbidities were obtained from self-report, general practitioners and medical records. The association of comorbidities or medical contacts with vaccination status was assessed using multivariable adjusted log-binomial regression models.
Among 1956 participants with available influenza vaccination data (median age 79 years, 45% women), 1314 (67%) received an influenza vaccination within the last year. Of 1400 patients with available pneumococcal vaccination data (median age 79 years, 46% women), prevalence of pneumococcal vaccination was 21% (n = 291). The prevalence of vaccination remained low in high-risk populations with chronic respiratory disease (34%) or diabetes (24%), but increased with an increasing number of outpatient medical contacts. Chronic respiratory disease was independently associated with the receipt of both influenza and pneumococcal vaccinations (prevalence ratio [PR] 1.09, 95% confidence interval [CI] 1.03-1.16; and PR 2.03, 95%CI 1.22-3.40, respectively), as was diabetes (PR 1.06, 95%CI 1.03-1.08; PR 1.24, 95%CI 1.16-1.34, respectively). An independent association was found between number of general practitioner visits and higher prevalence of pneumococcal vaccination (p for linear trend <0.001).
Uptake of influenza and particularly of pneumococcal vaccination in this population of European multimorbid older inpatients remains insufficient and is determined by comorbidities and number and type of health care contacts, especially outpatient medical visits. Hospitalization may be an opportunity to promote vaccination, particularly targeting patients with few outpatient physician contacts. |
---|---|
AbstractList | Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study was to investigate the prevalence and determinants of these vaccinations in this population. Multimorbid patients aged [greater than or equal to]70 years with polypharmacy were enrolled in 4 European centers in Switzerland, Belgium, the Netherlands, and Ireland. Data on vaccinations, demographics, health care contacts, and comorbidities were obtained from self-report, general practitioners and medical records. The association of comorbidities or medical contacts with vaccination status was assessed using multivariable adjusted log-binomial regression models. Among 1956 participants with available influenza vaccination data (median age 79 years, 45% women), 1314 (67%) received an influenza vaccination within the last year. Of 1400 patients with available pneumococcal vaccination data (median age 79 years, 46% women), prevalence of pneumococcal vaccination was 21% (n = 291). The prevalence of vaccination remained low in high-risk populations with chronic respiratory disease (34%) or diabetes (24%), but increased with an increasing number of outpatient medical contacts. Chronic respiratory disease was independently associated with the receipt of both influenza and pneumococcal vaccinations (prevalence ratio [PR] 1.09, 95% confidence interval [CI] 1.03-1.16; and PR 2.03, 95%CI 1.22-3.40, respectively), as was diabetes (PR 1.06, 95%CI 1.03-1.08; PR 1.24, 95%CI 1.16-1.34, respectively). An independent association was found between number of general practitioner visits and higher prevalence of pneumococcal vaccination (p for linear trend <0.001). Uptake of influenza and particularly of pneumococcal vaccination in this population of European multimorbid older inpatients remains insufficient and is determined by comorbidities and number and type of health care contacts, especially outpatient medical visits. Hospitalization may be an opportunity to promote vaccination, particularly targeting patients with few outpatient physician contacts. Background Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study was to investigate the prevalence and determinants of these vaccinations in this population. Methods Multimorbid patients aged [greater than or equal to]70 years with polypharmacy were enrolled in 4 European centers in Switzerland, Belgium, the Netherlands, and Ireland. Data on vaccinations, demographics, health care contacts, and comorbidities were obtained from self-report, general practitioners and medical records. The association of comorbidities or medical contacts with vaccination status was assessed using multivariable adjusted log-binomial regression models. Results Among 1956 participants with available influenza vaccination data (median age 79 years, 45% women), 1314 (67%) received an influenza vaccination within the last year. Of 1400 patients with available pneumococcal vaccination data (median age 79 years, 46% women), prevalence of pneumococcal vaccination was 21% (n = 291). The prevalence of vaccination remained low in high-risk populations with chronic respiratory disease (34%) or diabetes (24%), but increased with an increasing number of outpatient medical contacts. Chronic respiratory disease was independently associated with the receipt of both influenza and pneumococcal vaccinations (prevalence ratio [PR] 1.09, 95% confidence interval [CI] 1.03-1.16; and PR 2.03, 95%CI 1.22-3.40, respectively), as was diabetes (PR 1.06, 95%CI 1.03-1.08; PR 1.24, 95%CI 1.16-1.34, respectively). An independent association was found between number of general practitioner visits and higher prevalence of pneumococcal vaccination (p for linear trend <0.001). Conclusion Uptake of influenza and particularly of pneumococcal vaccination in this population of European multimorbid older inpatients remains insufficient and is determined by comorbidities and number and type of health care contacts, especially outpatient medical visits. Hospitalization may be an opportunity to promote vaccination, particularly targeting patients with few outpatient physician contacts. Background Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study was to investigate the prevalence and determinants of these vaccinations in this population. Methods Multimorbid patients aged ≥70 years with polypharmacy were enrolled in 4 European centers in Switzerland, Belgium, the Netherlands, and Ireland. Data on vaccinations, demographics, health care contacts, and comorbidities were obtained from self-report, general practitioners and medical records. The association of comorbidities or medical contacts with vaccination status was assessed using multivariable adjusted log-binomial regression models. Results Among 1956 participants with available influenza vaccination data (median age 79 years, 45% women), 1314 (67%) received an influenza vaccination within the last year. Of 1400 patients with available pneumococcal vaccination data (median age 79 years, 46% women), prevalence of pneumococcal vaccination was 21% (n = 291). The prevalence of vaccination remained low in high-risk populations with chronic respiratory disease (34%) or diabetes (24%), but increased with an increasing number of outpatient medical contacts. Chronic respiratory disease was independently associated with the receipt of both influenza and pneumococcal vaccinations (prevalence ratio [PR] 1.09, 95% confidence interval [CI] 1.03–1.16; and PR 2.03, 95%CI 1.22–3.40, respectively), as was diabetes (PR 1.06, 95%CI 1.03–1.08; PR 1.24, 95%CI 1.16–1.34, respectively). An independent association was found between number of general practitioner visits and higher prevalence of pneumococcal vaccination (p for linear trend <0.001). Conclusion Uptake of influenza and particularly of pneumococcal vaccination in this population of European multimorbid older inpatients remains insufficient and is determined by comorbidities and number and type of health care contacts, especially outpatient medical visits. Hospitalization may be an opportunity to promote vaccination, particularly targeting patients with few outpatient physician contacts. Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study was to investigate the prevalence and determinants of these vaccinations in this population. Multimorbid patients aged ≥70 years with polypharmacy were enrolled in 4 European centers in Switzerland, Belgium, the Netherlands, and Ireland. Data on vaccinations, demographics, health care contacts, and comorbidities were obtained from self-report, general practitioners and medical records. The association of comorbidities or medical contacts with vaccination status was assessed using multivariable adjusted log-binomial regression models. Among 1956 participants with available influenza vaccination data (median age 79 years, 45% women), 1314 (67%) received an influenza vaccination within the last year. Of 1400 patients with available pneumococcal vaccination data (median age 79 years, 46% women), prevalence of pneumococcal vaccination was 21% (n = 291). The prevalence of vaccination remained low in high-risk populations with chronic respiratory disease (34%) or diabetes (24%), but increased with an increasing number of outpatient medical contacts. Chronic respiratory disease was independently associated with the receipt of both influenza and pneumococcal vaccinations (prevalence ratio [PR] 1.09, 95% confidence interval [CI] 1.03-1.16; and PR 2.03, 95%CI 1.22-3.40, respectively), as was diabetes (PR 1.06, 95%CI 1.03-1.08; PR 1.24, 95%CI 1.16-1.34, respectively). An independent association was found between number of general practitioner visits and higher prevalence of pneumococcal vaccination (p for linear trend <0.001). Uptake of influenza and particularly of pneumococcal vaccination in this population of European multimorbid older inpatients remains insufficient and is determined by comorbidities and number and type of health care contacts, especially outpatient medical visits. Hospitalization may be an opportunity to promote vaccination, particularly targeting patients with few outpatient physician contacts. Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study was to investigate the prevalence and determinants of these vaccinations in this population.BACKGROUNDOlder adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study was to investigate the prevalence and determinants of these vaccinations in this population.Multimorbid patients aged ≥70 years with polypharmacy were enrolled in 4 European centers in Switzerland, Belgium, the Netherlands, and Ireland. Data on vaccinations, demographics, health care contacts, and comorbidities were obtained from self-report, general practitioners and medical records. The association of comorbidities or medical contacts with vaccination status was assessed using multivariable adjusted log-binomial regression models.METHODSMultimorbid patients aged ≥70 years with polypharmacy were enrolled in 4 European centers in Switzerland, Belgium, the Netherlands, and Ireland. Data on vaccinations, demographics, health care contacts, and comorbidities were obtained from self-report, general practitioners and medical records. The association of comorbidities or medical contacts with vaccination status was assessed using multivariable adjusted log-binomial regression models.Among 1956 participants with available influenza vaccination data (median age 79 years, 45% women), 1314 (67%) received an influenza vaccination within the last year. Of 1400 patients with available pneumococcal vaccination data (median age 79 years, 46% women), prevalence of pneumococcal vaccination was 21% (n = 291). The prevalence of vaccination remained low in high-risk populations with chronic respiratory disease (34%) or diabetes (24%), but increased with an increasing number of outpatient medical contacts. Chronic respiratory disease was independently associated with the receipt of both influenza and pneumococcal vaccinations (prevalence ratio [PR] 1.09, 95% confidence interval [CI] 1.03-1.16; and PR 2.03, 95%CI 1.22-3.40, respectively), as was diabetes (PR 1.06, 95%CI 1.03-1.08; PR 1.24, 95%CI 1.16-1.34, respectively). An independent association was found between number of general practitioner visits and higher prevalence of pneumococcal vaccination (p for linear trend <0.001).RESULTSAmong 1956 participants with available influenza vaccination data (median age 79 years, 45% women), 1314 (67%) received an influenza vaccination within the last year. Of 1400 patients with available pneumococcal vaccination data (median age 79 years, 46% women), prevalence of pneumococcal vaccination was 21% (n = 291). The prevalence of vaccination remained low in high-risk populations with chronic respiratory disease (34%) or diabetes (24%), but increased with an increasing number of outpatient medical contacts. Chronic respiratory disease was independently associated with the receipt of both influenza and pneumococcal vaccinations (prevalence ratio [PR] 1.09, 95% confidence interval [CI] 1.03-1.16; and PR 2.03, 95%CI 1.22-3.40, respectively), as was diabetes (PR 1.06, 95%CI 1.03-1.08; PR 1.24, 95%CI 1.16-1.34, respectively). An independent association was found between number of general practitioner visits and higher prevalence of pneumococcal vaccination (p for linear trend <0.001).Uptake of influenza and particularly of pneumococcal vaccination in this population of European multimorbid older inpatients remains insufficient and is determined by comorbidities and number and type of health care contacts, especially outpatient medical visits. Hospitalization may be an opportunity to promote vaccination, particularly targeting patients with few outpatient physician contacts.CONCLUSIONUptake of influenza and particularly of pneumococcal vaccination in this population of European multimorbid older inpatients remains insufficient and is determined by comorbidities and number and type of health care contacts, especially outpatient medical visits. Hospitalization may be an opportunity to promote vaccination, particularly targeting patients with few outpatient physician contacts. Background Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study was to investigate the prevalence and determinants of these vaccinations in this population. Methods Multimorbid patients aged ≥70 years with polypharmacy were enrolled in 4 European centers in Switzerland, Belgium, the Netherlands, and Ireland. Data on vaccinations, demographics, health care contacts, and comorbidities were obtained from self-report, general practitioners and medical records. The association of comorbidities or medical contacts with vaccination status was assessed using multivariable adjusted log-binomial regression models. Results Among 1956 participants with available influenza vaccination data (median age 79 years, 45% women), 1314 (67%) received an influenza vaccination within the last year. Of 1400 patients with available pneumococcal vaccination data (median age 79 years, 46% women), prevalence of pneumococcal vaccination was 21% (n = 291). The prevalence of vaccination remained low in high-risk populations with chronic respiratory disease (34%) or diabetes (24%), but increased with an increasing number of outpatient medical contacts. Chronic respiratory disease was independently associated with the receipt of both influenza and pneumococcal vaccinations (prevalence ratio [PR] 1.09, 95% confidence interval [CI] 1.03–1.16; and PR 2.03, 95%CI 1.22–3.40, respectively), as was diabetes (PR 1.06, 95%CI 1.03–1.08; PR 1.24, 95%CI 1.16–1.34, respectively). An independent association was found between number of general practitioner visits and higher prevalence of pneumococcal vaccination (p for linear trend <0.001). Conclusion Uptake of influenza and particularly of pneumococcal vaccination in this population of European multimorbid older inpatients remains insufficient and is determined by comorbidities and number and type of health care contacts, especially outpatient medical visits. Hospitalization may be an opportunity to promote vaccination, particularly targeting patients with few outpatient physician contacts. |
Audience | Academic |
Author | Aujesky, Drahomir Schwenkglenks, Matthias Del Giovane, Cinzia Rodondi, Nicolas Baretella, Oliver Dalleur, Olivia Feller, Martin Knol, Wilma Papazoglou, Dimitrios David Baumgartner, Christine Moutzouri, Elisavet O’Mahony, Denis |
AuthorAffiliation | 1 Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland 5 Department of Medicine Cork, University College Cork National University of Ireland, Munster, IE, Ireland Public Health England, UNITED KINGDOM 2 Department of General Internal Medicine, Inselspital, Bern University Hospital, Bern, Switzerland 3 Population Health Laboratory, University of Fribourg, Fribourg, Switzerland 8 Louvain Drug Research Institute, and Pharmacy Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium 6 Department of Geriatric Medicine Cork, Cork University Hospital Group, Munster, IE, Ireland 7 Department of Geriatrics and Expertise Centre Pharmacotherapy in Old Persons (EPHOR), University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands 4 Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland |
AuthorAffiliation_xml | – name: 5 Department of Medicine Cork, University College Cork National University of Ireland, Munster, IE, Ireland – name: 7 Department of Geriatrics and Expertise Centre Pharmacotherapy in Old Persons (EPHOR), University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands – name: Public Health England, UNITED KINGDOM – name: 2 Department of General Internal Medicine, Inselspital, Bern University Hospital, Bern, Switzerland – name: 4 Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland – name: 8 Louvain Drug Research Institute, and Pharmacy Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium – name: 3 Population Health Laboratory, University of Fribourg, Fribourg, Switzerland – name: 1 Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland – name: 6 Department of Geriatric Medicine Cork, Cork University Hospital Group, Munster, IE, Ireland |
Author_xml | – sequence: 1 givenname: Dimitrios David orcidid: 0000-0001-9544-105X surname: Papazoglou fullname: Papazoglou, Dimitrios David – sequence: 2 givenname: Oliver surname: Baretella fullname: Baretella, Oliver – sequence: 3 givenname: Martin surname: Feller fullname: Feller, Martin – sequence: 4 givenname: Cinzia surname: Del Giovane fullname: Del Giovane, Cinzia – sequence: 5 givenname: Elisavet surname: Moutzouri fullname: Moutzouri, Elisavet – sequence: 6 givenname: Drahomir surname: Aujesky fullname: Aujesky, Drahomir – sequence: 7 givenname: Matthias orcidid: 0000-0001-7217-1173 surname: Schwenkglenks fullname: Schwenkglenks, Matthias – sequence: 8 givenname: Denis surname: O’Mahony fullname: O’Mahony, Denis – sequence: 9 givenname: Wilma surname: Knol fullname: Knol, Wilma – sequence: 10 givenname: Olivia surname: Dalleur fullname: Dalleur, Olivia – sequence: 11 givenname: Nicolas orcidid: 0000-0001-9083-6896 surname: Rodondi fullname: Rodondi, Nicolas – sequence: 12 givenname: Christine surname: Baumgartner fullname: Baumgartner, Christine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34784405$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk1trFDEUxwep2It-A9GAIPqwayaZS8YHoRQvC4WCt9eQTTK7qZlkTDKr7Vfzy3lmd1t2SxGZhwz__M7_JCfnHGcHzjudZU9zPM1pnb-59ENwwk57kKeYVDjPyYPsKG8omVQE04Od_8PsOMZLjEvKqupRdkiLmhUFLo-yP2fBxziJWibjwQ7FNKgr5B1KS436oFfCaic18i0yrrWDdtcCCadQ7_TQeemlhKiVkNI4MXqsN02KSMTopdlov0xaoqUWFhbpnTKjGtdoMPEHaoVMPoDQebdASx97k4Q111qhbrDJdD7MjULeKh1QD57apfg4e9gKG_WT7XqSffvw_uvZp8n5xcfZ2en5RFYNSRM1V7QQNK-LklGBVV1XDEtRV7loCcMNIVIRwijUj1HSVlTlgpGSgpA3TVnTk-z5xre3PvJt3SMnZcNwVVSMADHbEMqLS94H04lwxb0wfC34sOAiJCOt5lQqqqmeU8ryoiibhkmVV3ASITA8lQSvd9tsw7zTSsJNg7B7pvs7ziz5wq84K5uCFRgMXm0Ngv856Jh4Z6LU1gqn_bA5d1ngmlSAvriD3n-7LbWAXuDQBR7yytGUn8J-XVJMC6Cm91DwKd0ZeHPdGtD3Al7vBQCT9O-0EEOMfPbl8_-zF9_32Zc77KbporfDuuX2wWe7lb4t8c10AFBsADkOSdDtLZJjPg7hTbn4OIR8O4QQ9vZOmIRuHtNDRYz9d_BfQyE7HA |
CitedBy_id | crossref_primary_10_1136_bmjopen_2023_082245 |
Cites_doi | 10.1331/154434503321831120 10.1086/502240 10.1007/s11606-011-1674-0 10.1371/journal.pone.0220848 10.1186/s12889-016-2884-5 10.1097/01.mlr.0000182534.19832.83 10.1016/j.vaccine.2005.06.005 10.1016/j.jval.2016.01.003 10.1093/cid/cis211 10.1183/09031936.00171309 10.1016/j.jinf.2012.02.017 10.1007/s10096-019-03485-3 10.4161/hv.3.3.3925 10.1007/s40273-019-00876-4 10.1186/1471-2288-3-21 10.1002/sim.7059 10.3390/ijerph14060665 10.1016/S0749-3797(98)00159-7 10.1007/s40273-018-0615-8 10.1186/s12890-017-0420-8 10.1001/jama.2013.279206 10.2807/1560-7917.ES.2019.24.29.1800446 10.1016/j.pmedr.2015.09.002 10.1016/j.vaccine.2004.12.031 10.1161/JAHA.116.004734 10.3201/eid0812.010497 10.1056/NEJMoa070844 10.1016/j.ahj.2004.07.028 10.1016/j.vaccine.2018.10.045 10.1371/journal.pone.0153848 10.1016/S1473-3099(18)30310-4 10.1056/NEJMoa1408544 10.1086/507340 10.1097/EDE.0000000000000984 10.1016/j.vaccine.2010.08.010 10.1086/429236 10.1136/bmj.c1004 10.1016/j.vaccine.2020.12.042 10.1186/1617-9625-4-12 10.1371/journal.pone.0147931 10.1016/j.amjmed.2014.05.002 10.1136/bmjopen-2018-026769 10.1016/S0264-410X(01)00068-8 10.1016/j.ypmed.2008.11.001 10.1371/journal.pmed.0040296 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 Public Library of Science 2021 Papazoglou et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 Papazoglou et al 2021 Papazoglou et al |
Copyright_xml | – notice: COPYRIGHT 2021 Public Library of Science – notice: 2021 Papazoglou et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 Papazoglou et al 2021 Papazoglou et al |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pone.0260112 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Agricultural Science Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Medicine Public Health |
DocumentTitleAlternate | Prevalence of influenza and pneumococcal vaccination and its determinants in multimorbid older inpatients |
EISSN | 1932-6203 |
ExternalDocumentID | 2598064682 oai_doaj_org_article_3cd3e3eb3381445998cd16af2aa0620c PMC8594840 A682753034 34784405 10_1371_journal_pone_0260112 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Netherlands Belgium Switzerland Ireland |
GeographicLocations_xml | – name: Switzerland – name: Belgium – name: Netherlands – name: Ireland |
GrantInformation_xml | – fundername: ; grantid: 320030_188549 – fundername: ; grantid: 634238 – fundername: ; grantid: 15.0137 |
GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM 3V. ADRAZ BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG PMFND 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 ESTFP PUEGO 5PM - 02 AAPBV ABPTK ADACO BBAFP KM |
ID | FETCH-LOGICAL-c692t-dbd34a3174583a0d77680ca761af280922cd2283112832f63d1a8253311199573 |
IEDL.DBID | M48 |
ISSN | 1932-6203 |
IngestDate | Sun Dec 05 00:11:29 EST 2021 Wed Aug 27 01:30:45 EDT 2025 Thu Aug 21 14:10:10 EDT 2025 Mon Sep 08 04:24:45 EDT 2025 Fri Jul 25 10:11:28 EDT 2025 Tue Jun 17 21:20:26 EDT 2025 Tue Jun 10 20:46:44 EDT 2025 Fri Jun 27 04:39:12 EDT 2025 Fri Jun 27 03:43:43 EDT 2025 Thu May 22 21:21:56 EDT 2025 Wed Feb 19 02:10:51 EST 2025 Thu Apr 24 22:58:35 EDT 2025 Tue Jul 01 01:49:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c692t-dbd34a3174583a0d77680ca761af280922cd2283112832f63d1a8253311199573 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. |
ORCID | 0000-0001-9083-6896 0000-0001-7217-1173 0000-0001-9544-105X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0260112 |
PMID | 34784405 |
PQID | 2598064682 |
PQPubID | 1436336 |
PageCount | e0260112 |
ParticipantIDs | plos_journals_2598064682 doaj_primary_oai_doaj_org_article_3cd3e3eb3381445998cd16af2aa0620c pubmedcentral_primary_oai_pubmedcentral_nih_gov_8594840 proquest_miscellaneous_2598540726 proquest_journals_2598064682 gale_infotracmisc_A682753034 gale_infotracacademiconefile_A682753034 gale_incontextgauss_ISR_A682753034 gale_incontextgauss_IOV_A682753034 gale_healthsolutions_A682753034 pubmed_primary_34784405 crossref_primary_10_1371_journal_pone_0260112 crossref_citationtrail_10_1371_journal_pone_0260112 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-11-16 |
PublicationDateYYYYMMDD | 2021-11-16 |
PublicationDate_xml | – month: 11 year: 2021 text: 2021-11-16 day: 16 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2021 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | LF Andrade (pone.0260112.ref036) 2020; 38 S Rehmet (pone.0260112.ref056) 2002; 8 T-H Collet (pone.0260112.ref063) 2011; 26 K Ludwig (pone.0260112.ref034) 2018; 36 pone.0260112.ref029 MP Nowalk (pone.0260112.ref060) 2003; 24 T Maruyama (pone.0260112.ref011) 2010; 340 pone.0260112.ref039 H Zhou (pone.0260112.ref003) 2012; 54 KM Kamal (pone.0260112.ref020) 2003; 43 K Zuercher (pone.0260112.ref046) 2019; 149 L Han (pone.0260112.ref048) 2019; 30 A Vila-Córcoles (pone.0260112.ref012) 2006; 43 J Santaularia (pone.0260112.ref045) 2016; 16 CF Christiansen (pone.0260112.ref031) 2014; 127 UA Ajani (pone.0260112.ref054) 2005; 149 VE Burns (pone.0260112.ref057) 2005; 23 À Domínguez (pone.0260112.ref009) 2005; 40 I Ridda (pone.0260112.ref024) 2007; 3 AJD Barros (pone.0260112.ref037) 2003; 3 J Bagaitkar (pone.0260112.ref049) 2008; 4 N Schmedt (pone.0260112.ref043) 2019; 14 Department of Health (pone.0260112.ref028) 2019 TD Szucs (pone.0260112.ref050) 2005; 23 pone.0260112.ref033 pone.0260112.ref006 O Blumenfeld (pone.0260112.ref030) 2017; 6 pone.0260112.ref004 BB Berry (pone.0260112.ref059) 2001; 19 À Domínguez (pone.0260112.ref023) 2016; 11 AJ van Hoek (pone.0260112.ref052) 2012; 65 pone.0260112.ref007 L Adam (pone.0260112.ref026) 2019; 9 MM Versteegh (pone.0260112.ref035) 2016; 19 K Kawakami (pone.0260112.ref010) 2010; 28 AR Tamhane (pone.0260112.ref038) 2016; 35 Department of Health (pone.0260112.ref027) 2019 PG Szilagyi (pone.0260112.ref058) 2020 WS Pearson (pone.0260112.ref047) 2009; 48 pone.0260112.ref040 pone.0260112.ref001 pone.0260112.ref002 A Vila-Córcoles (pone.0260112.ref022) 2019; 24 R Costello (pone.0260112.ref042) 2016; 11 C Bonnave (pone.0260112.ref014) 2019; 38 S Moberley (pone.0260112.ref016) 2013 pone.0260112.ref044 H Quan (pone.0260112.ref032) 2005; 43 pone.0260112.ref015 DPC Chan (pone.0260112.ref019) 2015; 2 pone.0260112.ref018 A Domínguez (pone.0260112.ref008) 2010; 36 JA Udell (pone.0260112.ref053) 2013; 310 K McFadden (pone.0260112.ref061) 2021; 39 M Ganczak (pone.0260112.ref025) 2017; 14 Q Wang (pone.0260112.ref021) 2018; 36 E von Elm (pone.0260112.ref041) 2007; 4 R Bekkat-Berkani (pone.0260112.ref051) 2017; 17 R Mac Donald (pone.0260112.ref062) 1999; 16 MJM Bonten (pone.0260112.ref013) 2015; 372 (pone.0260112.ref005) 2018; 18 KL Nichol (pone.0260112.ref017) 2007; 357 pone.0260112.ref055 |
References_xml | – volume-title: Influenza: the green book, chapter 19 year: 2019 ident: pone.0260112.ref027 – volume: 43 start-page: 403 issue: 3 year: 2003 ident: pone.0260112.ref020 article-title: Determinants of adult influenza and pneumonia immunization rates publication-title: Journal of the American Pharmacists Association doi: 10.1331/154434503321831120 – ident: pone.0260112.ref018 – ident: pone.0260112.ref033 – volume: 24 start-page: 526 issue: 7 year: 2003 ident: pone.0260112.ref060 article-title: Increasing pneumococcal vaccination rates among hospitalized patients publication-title: Infection Control & Hospital Epidemiology doi: 10.1086/502240 – volume: 26 start-page: 724 issue: 7 year: 2011 ident: pone.0260112.ref063 article-title: The quality of primary care in a country with universal health care coverage publication-title: Journal of general internal medicine doi: 10.1007/s11606-011-1674-0 – volume: 14 start-page: e0220848 issue: 8 year: 2019 ident: pone.0260112.ref043 article-title: Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany publication-title: PLoS One doi: 10.1371/journal.pone.0220848 – volume: 16 start-page: 185 issue: 1 year: 2016 ident: pone.0260112.ref045 article-title: Prevalence of influenza vaccination and its association with health conditions and risk factors among Kansas adults in 2013: a cross-sectional study publication-title: BMC Public Health doi: 10.1186/s12889-016-2884-5 – ident: pone.0260112.ref001 – volume: 43 issue: 11 year: 2005 ident: pone.0260112.ref032 article-title: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data publication-title: Medical Care doi: 10.1097/01.mlr.0000182534.19832.83 – volume: 23 start-page: 5055 issue: 43 year: 2005 ident: pone.0260112.ref050 article-title: Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons publication-title: Vaccine doi: 10.1016/j.vaccine.2005.06.005 – volume: 19 start-page: 343 issue: 4 year: 2016 ident: pone.0260112.ref035 article-title: Dutch tariff for the five-level version of EQ-5D publication-title: Value Health doi: 10.1016/j.jval.2016.01.003 – volume: 54 start-page: 1427 issue: 10 year: 2012 ident: pone.0260112.ref003 article-title: Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008 publication-title: Clin Infect Dis doi: 10.1093/cid/cis211 – volume: 36 start-page: 608 issue: 3 year: 2010 ident: pone.0260112.ref008 article-title: Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly publication-title: European Respiratory Journal doi: 10.1183/09031936.00171309 – volume: 65 start-page: 17 issue: 1 year: 2012 ident: pone.0260112.ref052 article-title: The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England publication-title: Journal of Infection doi: 10.1016/j.jinf.2012.02.017 – volume: 38 start-page: 785 issue: 4 year: 2019 ident: pone.0260112.ref014 article-title: Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-019-03485-3 – volume: 3 start-page: 83 issue: 3 year: 2007 ident: pone.0260112.ref024 article-title: Predictors of pneumococcal vaccination uptake in hospitalized patients aged 65 Years and over shortly following the commencement of a publicly funded national pneumococcal vaccination program in Australia publication-title: Human Vaccines doi: 10.4161/hv.3.3.3925 – volume: 38 start-page: 413 issue: 4 year: 2020 ident: pone.0260112.ref036 article-title: A french value set for the EQ-5D-5L publication-title: PharmacoEconomics doi: 10.1007/s40273-019-00876-4 – volume: 3 start-page: 21 issue: 1 year: 2003 ident: pone.0260112.ref037 article-title: Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio publication-title: BMC Medical Research Methodology doi: 10.1186/1471-2288-3-21 – volume-title: Pneumococcal: the green book, chapter 25 year: 2019 ident: pone.0260112.ref028 – ident: pone.0260112.ref040 – volume: 35 start-page: 5730 issue: 30 year: 2016 ident: pone.0260112.ref038 article-title: Prevalence odds ratio versus prevalence ratio: choice comes with consequences publication-title: Stat Med doi: 10.1002/sim.7059 – issue: 1 year: 2013 ident: pone.0260112.ref016 article-title: Vaccines for preventing pneumococcal infection in adults publication-title: Cochrane Database of Systematic Reviews – volume: 14 issue: 6 year: 2017 ident: pone.0260112.ref025 article-title: Coverage and influencing determinants of influenza vaccination in elderly patients in a country with a poor vaccination implementation publication-title: International Journal of Environmental Research and Public Health doi: 10.3390/ijerph14060665 – ident: pone.0260112.ref044 – volume: 16 start-page: 173 issue: 3 year: 1999 ident: pone.0260112.ref062 article-title: Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients publication-title: American Journal of Preventive Medicine doi: 10.1016/S0749-3797(98)00159-7 – volume: 36 start-page: 663 issue: 6 year: 2018 ident: pone.0260112.ref034 article-title: German value set for the EQ-5D-5L publication-title: Pharmacoeconomics doi: 10.1007/s40273-018-0615-8 – volume: 17 start-page: 79 issue: 1 year: 2017 ident: pone.0260112.ref051 article-title: Seasonal influenza vaccination in patients with COPD: a systematic literature review publication-title: BMC Pulmonary Medicine doi: 10.1186/s12890-017-0420-8 – volume: 310 start-page: 1711 issue: 16 year: 2013 ident: pone.0260112.ref053 article-title: Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis publication-title: Jama doi: 10.1001/jama.2013.279206 – volume: 24 start-page: 1800446 issue: 29 year: 2019 ident: pone.0260112.ref022 article-title: Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2019.24.29.1800446 – volume: 2 start-page: 803 year: 2015 ident: pone.0260112.ref019 article-title: Household characteristics and influenza vaccination uptake in the community-dwelling elderly: a cross-sectional study publication-title: Prev Med Rep doi: 10.1016/j.pmedr.2015.09.002 – ident: pone.0260112.ref002 – ident: pone.0260112.ref006 – year: 2020 ident: pone.0260112.ref058 article-title: Effect of patient portal reminders sent by a health care system on influenza vaccination rates: a randomized clinical trial publication-title: JAMA Intern Med – volume: 23 start-page: 3604 issue: 27 year: 2005 ident: pone.0260112.ref057 article-title: Factors influencing influenza vaccination uptake in an elderly, community-based sample publication-title: Vaccine doi: 10.1016/j.vaccine.2004.12.031 – ident: pone.0260112.ref039 – volume: 6 issue: 2 year: 2017 ident: pone.0260112.ref030 article-title: Trends in coronary revascularization and ischemic heart disease-related mortality in Israel publication-title: J Am Heart Assoc doi: 10.1161/JAHA.116.004734 – volume: 8 start-page: 1442 issue: 12 year: 2002 ident: pone.0260112.ref056 article-title: Cross-sectional study on influenza vaccination, Germany, 1999–2000 publication-title: Emerg Infect Dis doi: 10.3201/eid0812.010497 – volume: 357 start-page: 1373 issue: 14 year: 2007 ident: pone.0260112.ref017 article-title: Effectiveness of influenza vaccine in the community-dwelling elderly publication-title: New England Journal of Medicine doi: 10.1056/NEJMoa070844 – volume: 149 start-page: 254 issue: 2 year: 2005 ident: pone.0260112.ref054 article-title: Examining the coverage of influenza vaccination among people with cardiovascular disease in the United States publication-title: American Heart Journal doi: 10.1016/j.ahj.2004.07.028 – volume: 36 start-page: 7262 issue: 48 year: 2018 ident: pone.0260112.ref021 article-title: Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: a meta-analysis publication-title: Vaccine doi: 10.1016/j.vaccine.2018.10.045 – volume: 11 start-page: e0153848 issue: 4 year: 2016 ident: pone.0260112.ref042 article-title: Influenza and pneumococcal vaccination uptake in patients with rheumatoid arthritis treated with immunosuppressive therapy in the UK: a retrospective cohort study using data from the clinical practice research datalink publication-title: PLoS One doi: 10.1371/journal.pone.0153848 – volume: 18 start-page: 1191 issue: 11 year: 2018 ident: pone.0260112.ref005 article-title: Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(18)30310-4 – volume: 372 start-page: 1114 issue: 12 year: 2015 ident: pone.0260112.ref013 article-title: Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults publication-title: New England Journal of Medicine doi: 10.1056/NEJMoa1408544 – volume: 43 start-page: 860 issue: 7 year: 2006 ident: pone.0260112.ref012 article-title: Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study publication-title: Clinical Infectious Diseases doi: 10.1086/507340 – ident: pone.0260112.ref055 – ident: pone.0260112.ref007 – volume: 30 start-page: 405 issue: 3 year: 2019 ident: pone.0260112.ref048 article-title: Smoking and influenza-associated morbidity and mortality: a systematic review and meta-analysis publication-title: Epidemiology doi: 10.1097/EDE.0000000000000984 – volume: 28 start-page: 7063 issue: 43 year: 2010 ident: pone.0260112.ref010 article-title: Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan publication-title: Vaccine doi: 10.1016/j.vaccine.2010.08.010 – ident: pone.0260112.ref015 – volume: 40 start-page: 1250 issue: 9 year: 2005 ident: pone.0260112.ref009 article-title: Effectiveness of pneumococcal vaccination for elderly people in catalonia, spain: A case-control study publication-title: Clinical Infectious Diseases doi: 10.1086/429236 – volume: 340 start-page: c1004 year: 2010 ident: pone.0260112.ref011 article-title: Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial publication-title: BMJ doi: 10.1136/bmj.c1004 – volume: 39 start-page: 658 issue: 4 year: 2021 ident: pone.0260112.ref061 article-title: A review of hospital-based interventions to improve inpatient influenza vaccination uptake for high-risk adults publication-title: Vaccine doi: 10.1016/j.vaccine.2020.12.042 – volume: 4 start-page: 12 issue: 1 year: 2008 ident: pone.0260112.ref049 article-title: Tobacco use increases susceptibility to bacterial infection publication-title: Tobacco Induced Diseases doi: 10.1186/1617-9625-4-12 – volume: 11 start-page: e0147931 issue: 1 year: 2016 ident: pone.0260112.ref023 article-title: Factors associated with influenza vaccination of hospitalized elderly patients in Spain publication-title: PLOS ONE doi: 10.1371/journal.pone.0147931 – volume: 127 start-page: 871 issue: 9 year: 2014 ident: pone.0260112.ref031 article-title: Risk and prognosis of cancer in patients with nephrotic syndrome publication-title: Am J Med doi: 10.1016/j.amjmed.2014.05.002 – volume: 9 start-page: e026769 issue: 6 year: 2019 ident: pone.0260112.ref026 article-title: Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial publication-title: BMJ Open doi: 10.1136/bmjopen-2018-026769 – ident: pone.0260112.ref004 – ident: pone.0260112.ref029 – volume: 149 start-page: w14705 year: 2019 ident: pone.0260112.ref046 article-title: Trends in influenza vaccination uptake in Switzerland: Swiss Health Survey 2007 and 2012 publication-title: Swiss Med Wkly – volume: 19 start-page: 3493 issue: 25 year: 2001 ident: pone.0260112.ref059 article-title: Influenza vaccination is safe and immunogenic when administered to hospitalized patients publication-title: Vaccine doi: 10.1016/S0264-410X(01)00068-8 – volume: 48 start-page: 180 issue: 2 year: 2009 ident: pone.0260112.ref047 article-title: Influenza and pneumococcal vaccination rates among smokers: Data from the 2006 Behavioral Risk Factor Surveillance System publication-title: Preventive Medicine doi: 10.1016/j.ypmed.2008.11.001 – volume: 4 start-page: e296 issue: 10 year: 2007 ident: pone.0260112.ref041 article-title: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies publication-title: PLOS Medicine doi: 10.1371/journal.pmed.0040296 |
SSID | ssj0053866 |
Score | 2.382309 |
Snippet | Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with... Background Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated... Background Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated... |
SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | e0260112 |
SubjectTerms | Age Aged Aged patients Aged, 80 and over Ambulatory Care Analysis Belgium - epidemiology Biology and Life Sciences Care and treatment Chronic conditions Chronic Disease - classification Chronic Disease - drug therapy Chronic Disease - epidemiology Chronic illnesses Cochlear implants Comorbidity Complications Complications and side effects Confidence intervals Cross-Sectional Studies Demographics Demography Diabetes Diabetes mellitus Diagnosis Dosage and administration Ethics Female Health care Health risks Hospitals Humans Immunization Influenza Influenza vaccines Influenza Vaccines - administration & dosage Inpatients - statistics & numerical data Internal medicine Ireland - epidemiology Male Medical records Medicine Medicine and Health Sciences Mortality Multimorbidity Netherlands - epidemiology Older people Patient admissions Patient outcomes Patients People and Places Pharmacy Pneumococcal vaccine Pneumococcal Vaccines - administration & dosage Pneumonia Polypharmacy Polypharmacy - statistics & numerical data Population Prevalence Prevalence studies (Epidemiology) Primary care Public health Quality of life Regression analysis Regression models Respiratory diseases Risk analysis Risk Factors Self Report Statistical analysis Streptococcus infections Supervision Switzerland - epidemiology Transplants & implants Vaccination Vaccination - statistics & numerical data |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELXQnrggylcDBQaEBBzSJrHXyR5LRVWQAAko6i1ybKeN1CbRZpdD_xp_jhnbGxpUqRy4xuNNdp5nPJOM3zD2ap5XFsN6HaPrU7EwdR0rbedxrueyVoWShaTzzp8-y6Nj8fFkfnKl1RfVhHl6YK-4Pa4NtxxTPtxahJhjdqBNKlWdKZXILNHkfZNFskmmvA9GK5YyHJTjeboXcNntu9buOhatNJtsRI6vf_TKs_68G64LOf-unLyyFR3eZXdCDAn7_tm32C3b3mNbwUoHeBOopN_eZ78O6N7x4OqtaI5jk4WuBYz7oF8S1zdNgq6GxrcruVSgWgN9a9cXHXpLxBB-Kq0b_9rQDTarAdQfXIFe5oI_UQmYXxtfBuZEqXQdQlMfcJ2N4Cy0KmkurQFX0HjRLavGQEcdwyEwvQ4P2PHh--8HR3Fo1xBruchWsakMFwrjEfoUqxKTYyaTaJXLFNEqkkWWaUNkO6h7dCO15CZVmJ9yvEDnxHP-kM1aBGibga2I40ZoKXIjKl4ru1CVVMaaWha1qCLGN9iVOnCZU0uN89J9oMsxp_FQlIR4GRCPWDzO6j2Xxw3y72hZjLLExO0u4Posw_osb1qfEXtOi6r0IIz-pNyXRYapYsJFxF46CWLjaKnc51Sth6H88OXHPwh9-zoReh2E6g7VoVU4YoH_iVi-JpI7E0n0KXoyvE0msNHKUGKSXGDwigI4c2MW1w-_GIfpR6mEr7Xd2ssQ22MmI_bIW9GoWS7yQmDqELF8Yl8T1U9H2ubMkaEXxDckksf_A6sn7HZGJUtU5Sl32Gy1XNunGHOuqmfOvfwGeRWFLg priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fb9MwELdGJyEkhFiBLTDAICTgIVsau076gNA2bRpIK2gwtLfIsZ0t0paEpuVhX40vx53tdARNwGt8jhLfH9_Zd78j5NU4yQ249SoE0ydDrosilMqMw0SNRSFTKVKB9c5HU3F4wj-ejk9XyLSrhcG0ys4mWkOta4Vn5NvgpqewfYo0ft98D7FrFN6udi00pG-toN9ZiLFbZBVM8jgakNXd_enn4842g3YL4QvoWDLa9vzaaurKbFl0rVHc26Asjv_SWg-ai7q9yRX9M6Pyty3q4D65531LuuOEYY2smGpIbh_52_MhuevO6KgrPRqSNa_YLX3j0affPiA_9_CzwtamaOHrLAAtrSsKriJtZggPjpNoXdDSdTi5klRWmjaVWVzWYGCB7fQHrFXpThrtYDlvqbwWBYrnv9QVYVIIybXLHLOkmO1OfR8gapsh0XPf3aS8MpraHMjLepaXmtbYZJx6cNj2ITk52P-6dxj6Dg-hEpN4HupcMy7BhcHbWxnpBIKfSMlEjGQRp9EkjpVGfB5gC1ieQjA9khDSMniApeUJe0QGFfBug1CTIywOV4InmueskGYicyG10YVIC54HhHVszZSHP8cuHBeZvdNLIAxyXMpQGDIvDAEJl7MaB__xD_pdlJglLYJ32wf17CzztiBjSjPDTM7AW-Lw0ZNU6ZGAP5YyEnGkAvIc5S1zTFiaoGwHhB-iy4jxgLy0FAjgUWGG0JlctG324dO3_yD6ctwjeu2JihqWQ0lflQH_hMBgPcrNHiWYIdUb3kDt6Falza4VFmZ2GnPz8IvlML4Us_4qUy8cDQJExiIg607BlivLeJJyiDYCkvRUr7f0_ZGqPLf46SlCFPHo8d8_6wm5E2P-EqZ8ik0ymM8W5ik4oPP8mbcqvwAZnYt5 priority: 102 providerName: ProQuest |
Title | Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34784405 https://www.proquest.com/docview/2598064682 https://www.proquest.com/docview/2598540726 https://pubmed.ncbi.nlm.nih.gov/PMC8594840 https://doaj.org/article/3cd3e3eb3381445998cd16af2aa0620c http://dx.doi.org/10.1371/journal.pone.0260112 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELZGJ6G9IMavBUYxCAl4SJUmrp0-ILRVKwOJgQZFfYsc29kqdUlpWgT71_jnuHOcsKAiEC95iO_axJe73MXn7yPk6UCkBtJ65UPokz7TWeZLZQa-UAOeyVjymON-53cn_HjC3k4H0y1Sc7a6CSw3lnbIJzVZznvfvnx_BQ7_0rI2iH6t1FsUuelZjCykHd62K0bYzMeadQXwbs7dBro_ae6Q6xETMWPIaHflXWUh_ZvA3VnMi3JTVvp7c-WVt9X4Jrnh0kx6UD0Xu2TL5LfIrnPkkj53aNMvbpMfI_xvv7QtWahjAWdpkVNIDeliiXDgqESLjM4qRpNLSWWu6SI364sCAiqYmX6VSs2qL4t2cLYqqfxleorfe2m16ZJCCa6rTjErit3t1PH-UEt-RM8dm8ns0mhqex4vimU607RAUnHqwGDLO2QyPvo0OvYdo4Ov-DBc-TrVEZOQsuBqrQy0gGInUFLwvszCOBiGodKIxwNmgEiT8Uj3JZSwEZzAreQiuks6Odhqj1CTIgwOU5wJzdIok2YoUy610RmPM5Z6JKptlygHd46sG_PEruEJKHsqUyRo_MQZ3yN-o7Wo4D7-In-Ij0Uji2Dd9kSxPEuc7yeR0pGJTBpBdsTgooex0n0OdyxlwMNAeeQRPlRJZYQm5CQHPA6hmgwi5pEnVgIBO3LsCDqT67JM3rz__A9CH09bQs-cUFbAdCjpdmHAPSEQWEtyvyUJYUe1hvfQBepZKROoo2PIb0EANGu32Dz8uBnGH8Uuv9wU60oGASFD7pF7lRc1M1v7pEdEy79aU98eyWfnFi89RkgiFtz_b80HZCfEVibs_uT7pLNars1DyEVXaZdcE1MBx3jUx-P4dZdsHx6dfDjt2q87XRt-fgImDJT0 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwESQqx8rDCYQSDgIVsau076MKFtbOrYWtDY0N6CYztbpS0pTQti_xoSfxt3jtMRNAEve43PluP78Nm--x0hzzthYsCtVx6YPulxnaaeVKbjhaojUhlJEQnMd-4PRO-QvzvqHM2Rn1UuDIZVVjbRGmqdK7wjXwU3PYLtU0TBm9EXD6tG4etqVUJDutIKes1CjLnEjl3z_Rsc4Yq1nbfA7xdBsL11sNnzXJUBT4luMPF0ohmXsI3iC6L0dQgOuK8kHO9lGkR-NwiURowYcExA-lPBdFvCsYrBB0xvDhmMe43Mc7xAaZD5ja3Bh_1qLwBrIoRL2GNhe9XJx8ooz8yKRfNqB7UN0dYNmO0OjdFpXlzm-v4Zwfnblrh9h9x2vixdL4VvgcyZrEmu991rfZPcKu8EaZnq1CQLzpAU9JVDu359l_zYxGl5hQ0Jw-Es4C3NMwquKR2NEY4cO9E8pcOyosq5pDLTdJSZ6VkOBh3EjH4F3gzLm03bOJwUVF6IHsX7ZlomfVKV4zs96pslxeh66uoOUVt8iZ64airDc6Opjbk8y8fJUNMci5pTB0Zb3COHV8Lr-6SRAe8WCTUJwvBwJXioecJSaboyEVIbnYoo5UmLsIqtsXJw61j14zS2b4ghHLtKLsUoDLEThhbxZr1GJdzIP-g3UGJmtAgWbj_k4-PY2Z6YKc0MMwkD74zDpLuR0m0BfyylLwJftcgyyltcMmFm8uJ1UDY4zfqMt8gzS4GAIRlGJB3LaVHEO-8__QfRx_0a0UtHlOawHEq6LBD4JwQiq1Eu1SjB7Kla8yJqR7UqRXxhIKBnpTGXNz-dNeOgGGWYmXxa0iAgZSBa5EGpYLOVZTyMOJxuWiSsqV5t6est2fDE4rVHCInE_Yd_n9YyudE76O_FezuD3UfkZoCxUxhuKpZIYzKemsfg_E6SJ87CUPL5qo3aLwgkxLA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJ01ICLFyWWEwg0DAQ9Y0Tp30YUK7VRtjZRoM7S04trNV2pLQtCD21_gH_CrOcZyMoAl42Wt8HCU-V9vnfIeQ5_0g1hDWSwdMn3B8lSSOkLrvBLLPExEKHnKsd94f8Z0j_-1x_3iO_KxqYTCtsrKJxlCrTOIZeRfC9BDcJw-9bmLTIg62hm_yLw52kMKb1qqdhrBtFtSagRuzRR57-vs32M4Va7tbwPsXnjfc_ri549iOA47kA2_qqFgxX4BLxdtE4aoAgnFXCtjqi8QL3YHnSYV4MRCkgCYknKmegC0WgwdY6hwweO8NMh-A14eN4PzG9ujgsPILYFk4t8V7LOh1rays5lmqVw2yV89rOEfTQ6D2FK38LCuuCoP_zOb8zT0O75DbNq6l66UgLpI5nbbJwr69uW-TW-X5IC3Lntpk0RqVgr6yyNev75Ifm_hZTmHSw_B1BvyWZimFMJXmE4Qmx0k0S-i47K5yIahIFc1TPTvPwLiDyNGvwJtxecppBsfTgopLMaR49kzLAlAqM7yzR90zpJhpT20PImoaMdFT21llfKEVNfmX59kkHiuaYYNzaoFpi3vk6Fp4fZ-0UuDdEqE6RkgeX3I_UH7MEqEHIuZCaZXwMPHjDmEVWyNpodexA8hZZO4TA9iClVyKUBgiKwwd4tSz8hJ65B_0GygxNS0Ch5sH2eQksnYoYlIxzXTMIFLz4aMHoVQ9Dn8shMs9V3bICspbVDKhNn_ROige7Gxd5nfIM0OB4CEpquGJmBVFtPv-038QfThsEL20REkGyyGFrQiBf0JQsgblcoMSTKBsDC-hdlSrUkSXxgJmVhpz9fDTehhfihmHqc5mJQ2CU3q8Qx6UClavLPOD0IedTocEDdVrLH1zJB2fGuz2EOGRfPfh3z9rhSyAcYve7Y72HpGbHqZRYeYpXyat6WSmH0McPI2fWANDyefrtmm_AJuVyPQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cross-sectional+study+on+the+prevalence+of+influenza+and+pneumococcal+vaccination+and+its+association+with+health+conditions+and+risk+factors+among+hospitalized+multimorbid+older+patients&rft.jtitle=PloS+one&rft.au=Papazoglou%2C+Dimitrios+David&rft.au=Baretella%2C+Oliver&rft.au=Feller%2C+Martin&rft.au=Del+Giovane%2C+Cinzia&rft.date=2021-11-16&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=16&rft.issue=11&rft_id=info:doi/10.1371%2Fjournal.pone.0260112&rft_id=info%3Apmid%2F34784405&rft.externalDocID=PMC8594840 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |